
Zvolte si etiketu
zobrazeno přímo na lahvičceMazdutide
GLP-1
- Odesíláme z Německa
Objednávka
- DHL se sledováním zásilky
- Diskrétní balení
4.6 z 5 na Trustpilotu73 hodnocení
Hledáno také jako: Mazdutid · LY3305677 · IBI362
V kostce
Mazdutide v číslech
Klíčové údaje z našeho lexikonu.
Celé heslo v lexikonu- Class
- GLP-1 / glucagon dual agonistoxyntomodulin analogue
- Half-life
- Several daysweekly dose
- Frequency
- Once weeklysubcutaneous
- Form
- Lyophilised powderreconstituted with BAC water
- Sizes
- 5 to 10 mg2 sizes in the shop
What studies show
All 6 sources in the lexiconMeta-analysis of efficacy and safety (diabetics and non-diabetics) (opens in a new tab)
Frontiers in Endocrinology, 2024Phase 3 trial GLORY-1 in overweight and obesity in China (610 adults, 48 weeks) (opens in a new tab)
Ji et al., New England Journal of Medicine, 2025Phase 2 trial in the USA up to the highest study dose (48 weeks) (opens in a new tab)
Hsia et al., The Lancet Diabetes & Endocrinology, 2026
Hodnocení
Co říkají zákazníci
Jen skutečné objednávky, které obsahovaly Mazdutide.
Všechna hodnoceníPro Mazdutide zatím neexistuje laboratorní analýza. Hlasujte pro toNechte si to otestovat sami, polovinu zaplatímeVšechny laboratorní analýzy
Znalosti
Vše o Mazdutide
Podrobné informace připravujeme.
Dávkování
Načítání informací o dávkování …
Hodí se přiobjednat
Co k tomu potřebujete
Bakteriostatická voda se do košíku přidá automaticky. Stříkačky a tampony jedním kliknutím.
Inzulinové stříkačky
10 ks · 5.50 €
Alkoholové tampony
50 ks · 10 €
Kolik vody?
Jednotky na stříkačce pro vaši velikost lahvičky.
Otevřít kalkulačku →Is Mazdutide approved?
In China, yes. The first approval came in June 2025 for long-term weight management in obesity or overweight with a related condition, type 2 diabetes followed in September 2025. Mazdutide is not approved in the EU or the USA, ChEMBL lists phase 3 as the highest phase. The information here describes the state of research and is not a recommendation for use.
How does Mazdutide differ from Tirzepatide and Retatrutide?
The receptors. Mazdutide acts on GLP-1 and glucagon, Tirzepatide on GLP-1 and GIP, Retatrutide on all three. Mazdutide is derived from the gut hormone oxyntomodulin, which naturally addresses both receptors. A running trial with a higher dose compares it directly with Tirzepatide, there are no results yet.
What did the phase 3 trials show?
In GLORY-1 weight fell by 11.0 and 14.0 percent on average after 48 weeks, on placebo it rose by 0.3 percent. In GLORY-2 with a higher dose it was 16.7 versus 1.5 percent after 60 weeks. In type 2 diabetes HbA1c fell by 1.57 and 2.15 percentage points after 24 weeks (placebo 0.14). Against dulaglutide both doses were ahead for HbA1c and weight.
How long does Mazdutide stay in the body?
In the first phase 1b study in China the half-life was between 6.3 and 16.8 days. An attached fatty acid makes this possible. That fits one dose a week, which is how all trials give Mazdutide.
How high were the doses in trials?
The highest study dose was 16 mg per week, in a phase 1 study and a phase 2 trial in the USA. There weight fell by 18.1 percent after 32 weeks, but 20 percent stopped because of side effects. All trials raise the dose in steps over weeks. The entry describes the same principle: start low and only increase while there is no noticeable effect. This is not a dosing recommendation.
Which side effects were seen?
Mainly gastrointestinal effects, mostly mild to moderate. In GLORY-2 53.1 percent had vomiting, 46.9 percent nausea and 39.4 percent diarrhoea (placebo 1.3, 3.2 and 6.5 percent). In GLORY-1 only 0.5 to 1.5 percent stopped because of side effects. In an early study the complaints occurred mainly in the first dose levels.
Which trials are still running?
Four of the listed phase 3 trials are not finished yet: on fatty liver versus semaglutide, on sleep apnoea, in adolescents and on high blood pressure. Phase 2 trials are running on heart failure with obesity and on fatty liver with inflammation (MASH).
Související
Související produkty
Tirzepatide
Peptidy · GLP-1 a hubnutí GLP-1 a hubnutí
10 velikosti
Laboratorně testováno
= od 10 €/lahvička
Retatrutide
Peptidy · GLP-1 a hubnutí GLP-1 a hubnutí
11 velikosti
Laboratorně testováno
= od 16 €/lahvička
Semaglutide
Peptidy · GLP-1 a hubnutí GLP-1 a hubnutí
6 velikosti
Laboratorně testováno
= od 10 €/lahvička
Survodutide
Peptidy · GLP-1 a hubnutí GLP-1 a hubnutí
1 velikost
= 60.8 €/lahvička
Mazdutide